Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity

NCT07021937 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Obesity/Therapy

Interventions

DRUG: Semaglutide 1.7mg subcutaneous
DRUG: Placebo

Sponsor

University of Colorado, Denver

Collaborators

[object Object]
[object Object]